Fenoldopam

Fenoldopam
Clinical data


Trade names	Corlopam
AHFS/Drugs.com	Monograph
Routes of administration	IV
ATC code	C01CA19 (WHO)
Legal status
Legal status	US: ℞-only
Pharmacokinetic data
Metabolism	Hepatic (CYP not involved)
Elimination half-life	5 minutes
Excretion	Renal (90%) and fecal (10%)
Identifiers
IUPAC name (RS)-6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
CAS Number	67227-56-9^N
PubChem CID	3341
IUPHAR/BPS	939
DrugBank	DB00800^Y
ChemSpider	3224^Y
UNII	INU8H2KAWG
KEGG	D07946^N
ChEBI	CHEBI:5002^Y
ChEMBL	ChEMBL588^Y
CompTox Dashboard (EPA)	DTXSID0043896
Chemical and physical data
Formula	C₁₆H₁₆ClNO₃
Molar mass	305.76 g·mol⁻¹
3D model (JSmol)	Interactive image
Chirality	Racemic mixture
SMILES Clc1c3c(cc(O)c1O)C(c2ccc(O)cc2)CNCC3
InChI InChI=1S/C16H16ClNO3/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21/h1-4,7,13,18-21H,5-6,8H2^Y Key:TVURRHSHRRELCG-UHFFFAOYSA-N^Y
^NY (what is this?) (verify)

Fenoldopam mesylate (Corlopam) is a drug and synthetic benzazepine derivative which acts as a selective D₁ receptor partial agonist. Fenoldopam is used as an antihypertensive agent. It was approved by the Food and Drug Administration (FDA) in September 1997.